216 related articles for article (PubMed ID: 10645841)
1. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
Craig K; Gomez HF; McManus JL; Bania TC
J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841
[TBL] [Abstract][Full Text] [Related]
2. Gamma-hydroxybutyrate withdrawal syndrome.
Dyer JE; Roth B; Hyma BA
Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
[TBL] [Abstract][Full Text] [Related]
3. Successful management of prolonged gamma-hydroxybutyrate and alcohol withdrawal.
Bowles TM; Sommi RW; Amiri M
Pharmacotherapy; 2001 Feb; 21(2):254-7. PubMed ID: 11213862
[TBL] [Abstract][Full Text] [Related]
4. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
[TBL] [Abstract][Full Text] [Related]
5. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
McDaniel CH; Miotto KA
J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
[TBL] [Abstract][Full Text] [Related]
6. Inpatient management of GHB/GBL withdrawal.
Delic M
Psychiatr Danub; 2019 Sep; 31(Suppl 3):354-356. PubMed ID: 31488752
[TBL] [Abstract][Full Text] [Related]
7. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
8. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
Wojtowicz JM; Yarema MC; Wax PM
CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
McDonough M; Kennedy N; Glasper A; Bearn J
Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
[TBL] [Abstract][Full Text] [Related]
11. The gamma-hydroxybutyrate withdrawal syndrome.
Tarabar AF; Nelson LS
Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
[TBL] [Abstract][Full Text] [Related]
12. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol.
Schneir AB; Ly BT; Clark RF
J Emerg Med; 2001 Jul; 21(1):31-3. PubMed ID: 11399385
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
Liao PC; Chang HM; Chen LY
J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
[TBL] [Abstract][Full Text] [Related]
14. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence.
Galloway GP; Frederick SL; Staggers FE; Gonzales M; Stalcup SA; Smith DE
Addiction; 1997 Jan; 92(1):89-96. PubMed ID: 9060200
[TBL] [Abstract][Full Text] [Related]
15. Baclofen and gamma-hydroxybutyrate withdrawal.
LeTourneau JL; Hagg DS; Smith SM
Neurocrit Care; 2008; 8(3):430-3. PubMed ID: 18266111
[TBL] [Abstract][Full Text] [Related]
16. [GHB withdrawal delirium].
Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
[TBL] [Abstract][Full Text] [Related]
17. A case of severe withdrawal from gamma-hydroxybutyrate.
Chin RL
Ann Emerg Med; 2001 May; 37(5):551-2. PubMed ID: 11326198
[No Abstract] [Full Text] [Related]
18. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report.
Habibian S; Ahamad K; McLean M; Socias ME
J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765
[TBL] [Abstract][Full Text] [Related]
19. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
Busardò FP; Jones AW
Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
[TBL] [Abstract][Full Text] [Related]
20. [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts].
Lenzenhuber E; Müller C; Rommelspacher H; Spies C
Anaesthesist; 1999 Feb; 48(2):89-96. PubMed ID: 10093649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]